Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessMalaria

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial

PLOS Medicine·

Alessia Hysa, D. Herbert Opi, Joshua Waterhouse, Sandra Chishimba, Jessica L. Horton, Natalie Kingston, Hans J. Netter, David Wetzel, Michael Piontek, Gaoqian Feng, Jahit Sacarlal, Carlota Dobaño, Liriye Kurtovic, James G. Beeson

DOI
10.1371/journal.pmed.1004877
PMID
42133737
PMCID
PMC13186370
OpenAlex
W7161199452
Study type
Randomised controlled trial
Publisher
Public Library of Science (PLoS)
Article type
journal-article
Integrity
current

Why this research matters now

Mapping these precise humoral targets may assist researchers in designing future immunizations with enhanced longevity and defensive capability.

01

Structured evidence summary

Research question

The investigation aims to clarify undefined immune mechanisms and identify specific antibody markers linked to vaccine effectiveness against malaria.

Study design

Researchers conducted a post hoc evaluation of immunological data drawn from a phase IIb randomized controlled trial, supplemented by preclinical murine experiments and monoclonal antibody assays.

Population and setting

The clinical component enrolled children between one and four years of age, while animal models provided supplementary preclinical data.

Main findings

Elevated immunoglobulin G levels directed toward particular NANP-repeat and adjacent N-terminal sequences corresponded with a measurable decline in clinical malaria cases relative to participants with weaker responses. Cross-reactive binding patterns across distinct peptide regions were also documented.

Public-health relevance

Mapping these precise humoral targets may assist researchers in designing future immunizations with enhanced longevity and defensive capability.

Important limitations

The analysis relies on retrospective marker evaluation within an existing trial framework rather than prospective validation. Furthermore, this summary depends exclusively on the provided abstract and metadata, requiring the original manuscript for decision-grade interpretation.

GIDS interpretation

This work supplies baseline immunological context regarding vaccine-induced antibody profiles relevant to malaria prevention research. It serves as a reference for understanding humoral markers without suggesting active epidemiological monitoring or real-time signal detection.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 11 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseaddresses topicaddresses topicevaluates interventionevaluates interventionhas pathogen typestudied population settingstudies pathogenstudies populationstudies populationuses study design